Meg Heim
Meg Heim as VP, Global Head Strategic Scientific Engagement, Operations and Program Management, is a key member of the CMO Office. Meg’s role participates as a member of various Global teams and committees to further strengthen and globalize the Medical function across all Business Units and Countries.
Meg is responsible for crafting and executing the Integrated Scientific Strategy, harmonize Medical Systems, CRMs, Transparency Systems and lead the Innovative Scientific Congress model of the future.
Meg has held officer roles and Executive Global Medical, Sales and Marketing positions with a number of healthcare, medical device and health information technology companies.
Meg is a Registered Nurse with a Masters in Administrative Science, with Post Masters certificates in Non-Profit Organizational Development and Global Leadership from Fairleigh Dickinson University.
Danie du Plessis
Danie is currently EVP, Medical Affairs at Kyowa Kirin and Chair of the Medical affairs Professional Society (MAPS) board. He is a senior pharmaceutical executive with 30 years’ experience mainly in Medical Affairs. He has a passion for modernising medical affairs and track record in leadership, people development, capability building and coaching. Danie is a qualified MD with a Masters in Clinical Pharmacology who combines medical and life science qualifications with an MBA. Danie has extensive experience building international teams, driving change and working in regulated markets for GlaxoSmithKline (GSK) across Europe, the Americas, Middle East, Africa, Australasia and Japan. He previously worked for Eli Lilly & Company for 17 years in different medical roles as well as marketing and sales. During his different roles, he was based in South Africa, United Kingdom and Australia. Before joining the Pharmaceutical Industry, Danie had his own primary care practice.
Faisal Mehmud
Faisal joined BMS in July 2016 initially to lead the UK and Ireland Medical organisation, and is now Head of the European Medical group.
He has held a variety of senior leadership roles, most recently at Novartis in the USA, where he was the Vice President of US Clinical Development and Medical Affairs Oncology. Previously he was at GSK, where he was Head of the USA North American Medical Affairs/Clinical Development group for Oncology & Haematology and prior to this he held several roles of increasing seniority at GSK in the UK and at Sanofi in the UK and Paris, France (corporate).
He has extensive experience in late phase drug development, interaction with regulators, HTA bodies and academic co-operative groups globally over 15 years in a variety of therapeutic areas.
Faisal graduated in Medicine from Cambridge University, and before his time in industry, was a practicing physician in the UK in general medicine and oncology.
